Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: influence of long-term treatment with the antidepressant moclobemide - PubMed (original) (raw)
Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: influence of long-term treatment with the antidepressant moclobemide
I Sillaber et al. Neuroscience. 1998 Jul.
Abstract
In vivo microdialysis experiments were conducted in transgenic mice with impaired glucocorticoid receptor function resulting from expression of antisense directed against glucocorticoid receptor messenger RNA. Basal corticosterone and serotonin levels in the nucleus accumbens of untreated transgenic mice were enhanced compared to control mice (B6C3F1). Following a systemic morphine injection (15 mg/kg) mesolimbic dopamine and serotonin release was markedly increased in transgenic mice compared to control mice and in parallel enhanced behavioural stimulation was observed in these animals. After pretreatment with the antidepressant moclobemide over a time period of eight weeks (15 mg/kg/day) elevated basal levels of both corticosterone and serotonin were normalized in transgenic mice. Furthermore, morphine-induced dopamine and serotonin release as well as behavioral stimulation were suppressed in transgenic mice and similar to that in control mice. The results indicate that impaired glucocorticoid receptor function influences the basal release of serotonin in the nucleus accumbens. This alteration has no effect on basal but on morphine-stimulated release of dopamine in the mesolimbic system. An enhanced sensitivity to the effects of morphine is apparently related to elevated brain corticosterone and serotonin levels and can be normalized by long-term antidepressant treatment.
Similar articles
- Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function.
Montkowski A, Barden N, Wotjak C, Stec I, Ganster J, Meaney M, Engelmann M, Reul JM, Landgraf R, Holsboer F. Montkowski A, et al. J Neuroendocrinol. 1995 Nov;7(11):841-5. doi: 10.1111/j.1365-2826.1995.tb00724.x. J Neuroendocrinol. 1995. PMID: 8748120 - Microdialysis in the mouse nucleus accumbens: a method for detection of monoamine and amino acid neurotransmitters with simultaneous assessment of locomotor activity.
Olive MF, Mehmert KK, Hodge CW. Olive MF, et al. Brain Res Brain Res Protoc. 2000 Feb;5(1):16-24. doi: 10.1016/s1385-299x(99)00054-9. Brain Res Brain Res Protoc. 2000. PMID: 10719261 - Glucocorticoid receptor impairment alters CNS responses to a psychological stressor: an in vivo microdialysis study in transgenic mice.
Linthorst AC, Flachskamm C, Barden N, Holsboer F, Reul JM. Linthorst AC, et al. Eur J Neurosci. 2000 Jan;12(1):283-91. doi: 10.1046/j.1460-9568.2000.00878.x. Eur J Neurosci. 2000. PMID: 10651883 - Morphine-induced locomotor and neurochemical stimulation is enhanced in transgenic mice with impaired glucocorticoid receptor function.
Spanagel B, Stöhr T, Barden N, Holsboer F. Spanagel B, et al. J Neuroendocrinol. 1996 Feb;8(2):93-7. doi: 10.1111/j.1365-2826.1996.tb00828.x. J Neuroendocrinol. 1996. PMID: 8868255 - Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response.
Dremencov E, Weizmann Y, Kinor N, Gispan-Herman I, Yadid G. Dremencov E, et al. Curr Drug Targets. 2006 Feb;7(2):165-75. doi: 10.2174/138945006775515491. Curr Drug Targets. 2006. PMID: 16475958 Review.
Cited by
- Stress enables synaptic depression in CA1 synapses by acute and chronic morphine: possible mechanisms for corticosterone on opiate addiction.
Yang Y, Zheng X, Wang Y, Cao J, Dong Z, Cai J, Sui N, Xu L. Yang Y, et al. J Neurosci. 2004 Mar 10;24(10):2412-20. doi: 10.1523/JNEUROSCI.5544-03.2004. J Neurosci. 2004. PMID: 15014116 Free PMC article. - Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates.
Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S, Tassin JP. Drouin C, et al. J Neurosci. 2002 Apr 1;22(7):2873-84. doi: 10.1523/JNEUROSCI.22-07-02873.2002. J Neurosci. 2002. PMID: 11923452 Free PMC article. - Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways.
Taylor C, Fricker AD, Devi LA, Gomes I. Taylor C, et al. Cell Signal. 2005 May;17(5):549-57. doi: 10.1016/j.cellsig.2004.12.007. Cell Signal. 2005. PMID: 15683730 Free PMC article. Review. - Critical role of the embryonic mid-hindbrain organizer in the behavioral response to amphetamine and methylphenidate.
Tilleman H, Kofman O, Nashelsky L, Livneh U, Roz N, Sillaber I, Biegon A, Rehavi M, Brodski C. Tilleman H, et al. Neuroscience. 2009 Nov 10;163(4):1012-23. doi: 10.1016/j.neuroscience.2009.07.040. Epub 2009 Jul 24. Neuroscience. 2009. PMID: 19635527 Free PMC article. - Increase in clusterin-containing follicles in the adenohypophysis of drug abusers.
Ishikawa T, Zhu BL, Miyaishi S, Ishizu H, Maeda H. Ishikawa T, et al. Int J Legal Med. 2007 Sep;121(5):395-402. doi: 10.1007/s00414-006-0138-2. Epub 2006 Nov 18. Int J Legal Med. 2007. PMID: 17115171